Changzhou Pharm Company Profile
What is the competitive landscape for CHANGZHOU PHARM
CHANGZHOU PHARM has four approved drugs.
There is one tentative approval on CHANGZHOU PHARM drugs.
Summary for Changzhou Pharm
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Changzhou Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Changzhou Pharm | TICAGRELOR | ticagrelor | TABLET;ORAL | 216187-001 | Oct 28, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Changzhou Pharm | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207408-001 | Oct 31, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Changzhou Pharm | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207408-003 | Oct 31, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Changzhou Pharm | TICAGRELOR | ticagrelor | TABLET;ORAL | 216187-002 | Oct 28, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Changzhou Pharm | DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET;ORAL | 211343-001 | Oct 9, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
